Clinical Trial Update: An Open Label Extension of a Study of Topiramate in Chronic Migraine. [Phase 3]

View source ↗

Summary

Open-label extension of a Phase 3 study evaluating topiramate for chronic migraine; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Topamax (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Migraine | Phase 3 | Status: COMPLETED